BNTC Similar Chart Price Prediction
The price of BNTC is predicted to go up -12.28%, based on the high correlation periods with APLD. The similarity of these two price pattern on the periods is 91.54%.
BNTC
APLD
Down: -12.28%Similarity: 91.54%
BNTC Revenue Forecast
BNTC EPS Forecast
BNTC FAQs
What is bull’s view on BNTC?
What is bear's view on BNTC?
BNTC Analyst's Forecast
Brian Skorney
Baird
Buy
2024-12-13
Price Target
$30
Upside
+159.07%
Baird initiated coverage of Benitec Biopharma with an Outperform rating and $30 price target. The firm says Benitec's BB-301 gene therapy packages siRNA and healthy protein into a one-time treatment of oculopharyngeal muscular dystrophy, a disease with high unmet need, no currently approved treatments, and no disease-modifying assets in the clinic other than BB-301. B-301 has greatly improved patients' ability to swallow with a clean safety profile to date, and the trial design provides a regular cadence of data updates over the next year, the analyst tells investors in a research note.
Silvan Tuerkcan
JMP Securities
Buy
2024-10-14
Price Target
$16 → $18
Upside
+77.17%
